ftInvstr
LINCOLN · Healthcare ₹521.35 +1.49% Mkt Cap ₹1034 Cr fair
← Search another stock

LINCOLN

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹521.35
+1.49% today · 30d -6.58%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for LINCOLN. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹191 Cr
+17.13% YoY
NET PROFIT
₹20 Cr
+2.21% YoY
OPM
16.54%
-2.61pp YoY
EPS
₹10.2
PE 10.8
Intrinsic value · DCF ₹539.60 · Margin of safety +3.5% (fair) · FCF yield 7.83%
◇ Sector Position
PEERPEROCE %
LINCOLN10.817.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
66
SCORE / 100
Overall
6-axis composite of the sections below.
Performance POSITIVE 55
Valuation CHEAP 75
Growth STEADY 53
Profitability HIGH 78
Technicals WEAK 47
Risk LOW 90
Key Stats
TTM PE
10.8
P/B
1.29
52W HIGH
₹770.0
OFF HIGH
-32.29%
DIV YIELD
0.35%
MKT CAP
₹1034 Cr
◉ Active Signals
MACDNeutral1.8273
RSI(14)Neutral45.15
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold LINCOLN and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.